ArticleCureus2026
Severe Hepatic Iron Overload and Cirrhosis in an HFE C282Y Heterozygote With Autoimmune Hepatitis: A Case of Genotype-Phenotype Discordance.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hereditary hemochromatosis is a disorder of iron metabolism characterized by increased intestinal iron absorption and progressive parenchymal iron deposition, most commonly associated with homozygous mutations in the HFE gene. In contrast, heterozygous carriers of HFE mutations are generally considered to have low clinical penetrance and are not expected to develop clinically significant iron overload or advanced liver disease. However, iron homeostasis may be substantially altered in the presence of chronic liver inflammation and immune-mediated hepatic injury. We present the case of a woman in her early 60s with a heterozygous HFE C282Y mutation who developed marked hyperferritinemia, biopsy-confirmed hepatic iron overload, and established cirrhosis in the setting of autoimmune hepatitis treated with mycophenolate mofetil. Her clinical course was notable for wide fluctuations in ferritin levels over several years, with a peak exceeding 3,800 ng/mL, and subsequent sustained reduction following therapeutic phlebotomy. Management was complicated by anemia, requiring individualized phlebotomy thresholds and transition to a maintenance strategy. This case highlights the diagnostic challenges of interpreting iron indices in patients with inflammatory liver disease and demonstrates that clinically significant iron overload may occur in HFE heterozygotes when additional disease modifiers are present. It underscores the importance of histologic confirmation of iron overload in cases of genotype-phenotype discordance and reinforces the need for individualized management strategies in complex iron-loading conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.